Search

Your search keyword '"Homsi, Jade"' showing total 268 results
Start Over Author "Homsi, Jade"
268 results on '"Homsi, Jade"'

1. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.

Author

Choy, Edwin, Connelly, Mary, Dry, Sarah, Ganjoo, Kristen, Gonzalez, Ricardo, Holder, Ashley, Homsi, Jade, Keedy, Vicki, Kelly, Ciara, Kim, Edward, Liebner, David, McCarter, Martin, McGarry, Sean, Mesko, Nathan, Meyer, Christian, Pappo, Alberto, Parkes, Amanda, Petersen, Ivy, Poppe, Matthew, Schuetze, Scott, Shabason, Jacob, Spraker, Matthew, Zimel, Melissa, Bergman, Mary, Sundar, Hema, Hang, Lisa, von Mehren, Margaret, Kane, John, Riedel, Richard, Sicklick, Jason, Pollack, Seth, Agulnik, Mark, Bui, Marilyn, and Carr-Ascher, Janai

Subjects
Humans, Gastrointestinal Stromal Tumors, Receptor, Platelet-Derived Growth Factor alpha, Proto-Oncogene Proteins c-kit, Mutation
Abstract

Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines for GIST provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with these tumors. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised systemic therapy options for unresectable, progressive, or metastatic GIST based on mutational status, and updated recommendations for the management of GIST that develop resistance to specific tyrosine kinase inhibitors.

Published
2022

2. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Author

von Mehren, Margaret, Kane, John M, Agulnik, Mark, Bui, Marilyn M, Carr-Ascher, Janai, Choy, Edwin, Connelly, Mary, Dry, Sarah, Ganjoo, Kristen N, Gonzalez, Ricardo J, Holder, Ashley, Homsi, Jade, Keedy, Vicki, Kelly, Ciara M, Kim, Edward, Liebner, David, McCarter, Martin, McGarry, Sean V, Mesko, Nathan W, Meyer, Christian, Pappo, Alberto S, Parkes, Amanda M, Petersen, Ivy A, Pollack, Seth M, Poppe, Matthew, Riedel, Richard F, Schuetze, Scott, Shabason, Jacob, Sicklick, Jason K, Spraker, Matthew B, Zimel, Melissa, Hang, Lisa E, Sundar, Hema, and Bergman, Mary Anne

Subjects
Biomedical and Clinical Sciences, Health Sciences, Clinical Sciences, Oncology and Carcinogenesis, Orphan Drug, Clinical Trials and Supportive Activities, Pediatric Cancer, Rare Diseases, Cancer, Clinical Research, Pediatric, Extremities, Humans, Medical Oncology, Sarcoma, Soft Tissue Neoplasms, Oncology & Carcinogenesis, Oncology and carcinogenesis, Health services and systems
Abstract

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recommendations, and reviews the evidence to support the guidelines recommendations.

Published
2022

3. Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

Author

Gross, Neil D, Miller, David M, Khushalani, Nikhil I, Divi, Vasu, Ruiz, Emily S, Lipson, Evan J, Meier, Friedegund, Su, Yungpo Bernard, Swiecicki, Paul L, Atlas, Jennifer, Geiger, Jessica L, Hauschild, Axel, Choe, Jennifer H, Hughes, Brett G M, Schadendorf, Dirk, Patel, Vishal A, Homsi, Jade, Taube, Janis M, Lim, Annette M, Ferrarotto, Renata, Yoo, Suk-Young, Mathias, Melissa, Han, Hyunsil, Seebach, Frank, Lowy, Israel, Fury, Matthew G, and Rischin, Danny

Published
2023
Full Text
View/download PDF

4. Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice

Author

von Itzstein, Mitchell S., primary, Yang, Yuqiu, additional, Wang, Yiqing, additional, Hsiehchen, David, additional, Sheffield, Thomas Y., additional, Fattah, Farjana, additional, Popat, Vinita, additional, Ahmed, Murtaza, additional, Homsi, Jade, additional, Dowell, Jonathan E., additional, Rashdan, Sawsan, additional, Lohrey, Jay, additional, Hammers, Hans J., additional, Hughes, Randall S., additional, Wang, Tao, additional, Xie, Yang, additional, and Gerber, David E., additional

Published
2024
Full Text
View/download PDF

6. Abstract 9343: Predictive Value of Baseline Serum High-Sensitivity Troponin I and NT-proBNP for Cardiac Immunotoxicity Risk During Immune Checkpoint Inhibitor Therapy

Author

Rao, Anjali, Prasad, Tanushree, Simon, Shayna, Zhu, Hong, Venkatesh, Vishnu, Ali, Sadia, Bermas, Bonnie, Bernabela, Luigino, Bhai, Salman, Brugarolas, James, Castillo, Pedro, Chandra, Alvin, Dao, Kathryn, Mammen, Pradeep P, Garg, Sonia, Homsi, Jade, Oz, Orhan, Ratti, Gregory, Selby, Chris, Vallabhaneni, Srilakshmi, Zhang, Kathleen, De Lemos, James A, Sweetenham, John, Hammers, Hans, and Zaha, Vlad G

Published
2022
Full Text
View/download PDF

7. Supplementary Fig. 1B from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Author

Huang, Ryan, primary, Liu, Xiaoye, primary, Kim, Jaehyup, primary, Deng, Hui, primary, Deng, Mi, primary, Gui, Xun, primary, Chen, Heyu, primary, Wu, Guojin, primary, Xiong, Wei, primary, Xie, Jingjing, primary, Lewis, Cheryl, primary, Homsi, Jade, primary, Yang, Xing, primary, Zhang, Chengcheng, primary, He, Yubo, primary, Lou, Qi, primary, Smith, Caroline, primary, John, Samuel, primary, Zhang, Ningyan, primary, An, Zhiqiang, primary, and Zhang, Cheng Cheng, primary

Published
2024
Full Text
View/download PDF

8. Data from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Author

Huang, Ryan, primary, Liu, Xiaoye, primary, Kim, Jaehyup, primary, Deng, Hui, primary, Deng, Mi, primary, Gui, Xun, primary, Chen, Heyu, primary, Wu, Guojin, primary, Xiong, Wei, primary, Xie, Jingjing, primary, Lewis, Cheryl, primary, Homsi, Jade, primary, Yang, Xing, primary, Zhang, Chengcheng, primary, He, Yubo, primary, Lou, Qi, primary, Smith, Caroline, primary, John, Samuel, primary, Zhang, Ningyan, primary, An, Zhiqiang, primary, and Zhang, Cheng Cheng, primary

Published
2024
Full Text
View/download PDF

9. Supplementary Tables from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Author

Huang, Ryan, primary, Liu, Xiaoye, primary, Kim, Jaehyup, primary, Deng, Hui, primary, Deng, Mi, primary, Gui, Xun, primary, Chen, Heyu, primary, Wu, Guojin, primary, Xiong, Wei, primary, Xie, Jingjing, primary, Lewis, Cheryl, primary, Homsi, Jade, primary, Yang, Xing, primary, Zhang, Chengcheng, primary, He, Yubo, primary, Lou, Qi, primary, Smith, Caroline, primary, John, Samuel, primary, Zhang, Ningyan, primary, An, Zhiqiang, primary, and Zhang, Cheng Cheng, primary

Published
2024
Full Text
View/download PDF

10. Supplementary Fig. 2 from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Author

Huang, Ryan, primary, Liu, Xiaoye, primary, Kim, Jaehyup, primary, Deng, Hui, primary, Deng, Mi, primary, Gui, Xun, primary, Chen, Heyu, primary, Wu, Guojin, primary, Xiong, Wei, primary, Xie, Jingjing, primary, Lewis, Cheryl, primary, Homsi, Jade, primary, Yang, Xing, primary, Zhang, Chengcheng, primary, He, Yubo, primary, Lou, Qi, primary, Smith, Caroline, primary, John, Samuel, primary, Zhang, Ningyan, primary, An, Zhiqiang, primary, and Zhang, Cheng Cheng, primary

Published
2024
Full Text
View/download PDF

11. Supplementary Fig. 3 from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Author

Huang, Ryan, primary, Liu, Xiaoye, primary, Kim, Jaehyup, primary, Deng, Hui, primary, Deng, Mi, primary, Gui, Xun, primary, Chen, Heyu, primary, Wu, Guojin, primary, Xiong, Wei, primary, Xie, Jingjing, primary, Lewis, Cheryl, primary, Homsi, Jade, primary, Yang, Xing, primary, Zhang, Chengcheng, primary, He, Yubo, primary, Lou, Qi, primary, Smith, Caroline, primary, John, Samuel, primary, Zhang, Ningyan, primary, An, Zhiqiang, primary, and Zhang, Cheng Cheng, primary

Published
2024
Full Text
View/download PDF

12. LILRB3 supports immunosuppressive activity of myeloid cells and tumor development

Author

Huang, Ryan, primary, Liu, Xiaoye, additional, Kim, Jaehyup, additional, Deng, Hui, additional, Deng, Mi, additional, Gui, Xun, additional, Chen, Heyu, additional, Wu, Guojin, additional, Xiong, Wei, additional, Xie, Jingjing, additional, Lewis, Cheryl, additional, Homsi, Jade, additional, Yang, Xing, additional, Zhang, Chengcheng, additional, He, Yubo, additional, Lou, Qi, additional, Smith, Caroline, additional, John, Samuel, additional, Zhang, Ningyan, additional, and An, Zhiqiang, additional

Published
2023
Full Text
View/download PDF

13. pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding

Author

Han, Yi, primary, Yang, Yuqiu, additional, Tian, Yanhua, additional, Fattah, Farjana J., additional, Itzstein, Mitchell S. von, additional, Hu, Yifei, additional, Zhang, Minying, additional, Kang, Xiongbin, additional, Yang, Donghan M., additional, Liu, Jialiang, additional, Xue, Yaming, additional, Liang, Chaoying, additional, Raman, Indu, additional, Zhu, Chengsong, additional, Xiao, Olivia, additional, Dowell, Jonathan E., additional, Homsi, Jade, additional, Rashdan, Sawsan, additional, Yang, Shengjie, additional, Gwin, Mary E., additional, Hsiehchen, David, additional, Gloria-McCutchen, Yvonne, additional, Pan, Ke, additional, Wu, Fangjiang, additional, Gibbons, Don, additional, Wang, Xinlei, additional, Yee, Cassian, additional, Huang, Junzhou, additional, Reuben, Alexandre, additional, Cheng, Chao, additional, Zhang, Jianjun, additional, Gerber, David E., additional, and Wang, Tao, additional

Published
2023
Full Text
View/download PDF

14. Chemical Castration of Melanoma Patients Does Not Increase the Frequency of Tumor-specific CD4 and CD8 T Cells After Peptide Vaccination

Author

Vence, Luis M, Wang, Chiyu, Pappu, Himabindu, Anson, Ryan E, Patel, Tejal A, Miller, Priscilla, Bassett, Roland, Lizee, Gregory, Overwijk, Willem W, Komanduri, Krishna, Benjamin, Cara, Alvarado, Gladys, Patel, Sapna P, Kim, Kevin, Papadopoulos, Nicholas E, Bedikian, Agop Y, Homsi, Jade, Hwu, Wen-Jen, Boyd, Richard, Radvanyi, Laszlo, and Hwu, Patrick

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Trials and Supportive Activities, Prevention, Immunization, Cancer, Vaccine Related, Clinical Research, Prevention of disease and conditions, and promotion of well-being, 3.4 Vaccines, Adult, Aged, Aged, 80 and over, Antigens, Neoplasm, Antineoplastic Agents, Hormonal, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cancer Vaccines, Female, Humans, Interleukin-7, Leuprolide, Lymphocyte Count, Male, Melanoma, Middle Aged, Neoplasm Proteins, Neoplasm Staging, Receptors, Antigen, T-Cell, Treatment Outcome, Vaccines, Subunit, Young Adult, gp100 Melanoma Antigen, Oncology and carcinogenesis
Abstract

Peptide vaccination against tumor-associated antigens remains one of the most common methods of immunization in cancer vaccine clinical trials. Although peptide vaccination has been reported to increase circulating antigen-specific T-cells, they have had limited clinical efficacy and there is a necessity to increase their capacity to generate strong antitumor responses. We sought to improve the clinical efficacy of peptide-based vaccines in cancer immunotherapy of metastatic melanoma using a LHRH agonist (leuprolide) as adjuvant. Seventy HLA-A*0201 stage IIb-IV melanoma patients were vaccinated with class I HLA-A*0201-restricted gp100209-2M peptide and stratified for HLA-DP4 restriction. HLA-DP4 patients were also vaccinated with class II HLA-DP4-restricted MAGE-3243-258 peptide. Patients from both groups were randomized to receive 2 doses of leuprolide or not. Here we report the increase in PBMC TREC levels at week 24 after peptide vaccination, which was independent of the leuprolide treatment. This change was mirrored by a small increase in the TREC-enriched CD8CD45RAROCD27CD103, but not the TREC-enriched CD4CD45RAROCD31 T-cell population. Serum concentration of 2 important factors for thymopoiesis was measured: insulin growth factor 1 (IGF-1) levels were not changed, whereas a moderate increase in IL-7 levels was noted in the sera of all patients 6 weeks after vaccination. Increased expression of CD127 (IL-7 receptor-α) at week 24, compared with baseline, was only seen in the CD8CD45RAROCD27CD103 T-cell population. Our results suggest that leuprolide has no effect on thymic output when used as peptide vaccine adjuvant, but IFA-based peptide vaccination may unexpectedly affect the thymus by increasing thymic output of new T cells.

Published
2013

15. Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors

Author

Mundra, Vatsala, primary, Yang, Yuqiu, additional, von Itzstein, Mitchell S., additional, Fattah, Farjana, additional, Gonugunta, Amrit S., additional, Hannan, Raquibul, additional, Pop, Laurentiu M., additional, Zhang, Yuanyuan, additional, Wang, Yiqing, additional, Sheffield, Thomas, additional, Xie, Yang, additional, Dowell, Jonathan E., additional, Homsi, Jade, additional, Rashdan, Sawsan, additional, Park, Jason, additional, Li, Quan-Zhen, additional, Wakeland, Edward K., additional, and Gerber, David E., additional

Published
2023
Full Text
View/download PDF

17. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

Author

Deng, Mi, Gui, Xun, Kim, Jaehyup, Xie, Li, Chen, Weina, Li, Zunling, He, Licai, Chen, Yuanzhi, Chen, Heyu, Luo, Weiguang, Lu, Zhigang, Xie, Jingjing, Churchill, Hywyn, Xu, Yixiang, Zhou, Zhan, Wu, Guojin, Yu, Chenyi, John, Samuel, Hirayasu, Kouyuki, Nguyen, Nam, Liu, Xiaoye, Huang, Fangfang, Li, Leike, Deng, Hui, Tang, Haidong, Sadek, Ali H., Zhang, Lingbo, Huang, Tao, Zou, Yizhou, Chen, Benjamin, Zhu, Hong, Arase, Hisashi, Xia, Ningshao, Jiang, Youxing, Collins, Robert, You, M. James, Homsi, Jade, Unni, Nisha, Lewis, Cheryl, Chen, Guo-Qiang, Fu, Yang-Xin, Liao, X. Charlene, An, Zhiqiang, Zheng, Junke, Zhang, Ningyan, and Zhang, Cheng Cheng

Published
2018
Full Text
View/download PDF

21. Supplementary Table 3 - 4 from Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Author

Radvanyi, Laszlo G., primary, Bernatchez, Chantale, primary, Zhang, Minying, primary, Fox, Patricia S., primary, Miller, Priscilla, primary, Chacon, Jessica, primary, Wu, Richard, primary, Lizee, Gregory, primary, Mahoney, Sandy, primary, Alvarado, Gladys, primary, Glass, Michelle, primary, Johnson, Valen E., primary, McMannis, John D., primary, Shpall, Elizabeth, primary, Prieto, Victor, primary, Papadopoulos, Nicholas, primary, Kim, Kevin, primary, Homsi, Jade, primary, Bedikian, Agop, primary, Hwu, Wen-Jen, primary, Patel, Sapna, primary, Ross, Merrick I., primary, Lee, Jeffrey E., primary, Gershenwald, Jeffrey E., primary, Lucci, Anthony, primary, Royal, Richard, primary, Cormier, Janice N., primary, Davies, Michael A., primary, Mansaray, Rahmatu, primary, Fulbright, Orenthial J., primary, Toth, Christopher, primary, Ramachandran, Renjith, primary, Wardell, Seth, primary, Gonzalez, Audrey, primary, and Hwu, Patrick, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 2 from Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Author

Radvanyi, Laszlo G., primary, Bernatchez, Chantale, primary, Zhang, Minying, primary, Fox, Patricia S., primary, Miller, Priscilla, primary, Chacon, Jessica, primary, Wu, Richard, primary, Lizee, Gregory, primary, Mahoney, Sandy, primary, Alvarado, Gladys, primary, Glass, Michelle, primary, Johnson, Valen E., primary, McMannis, John D., primary, Shpall, Elizabeth, primary, Prieto, Victor, primary, Papadopoulos, Nicholas, primary, Kim, Kevin, primary, Homsi, Jade, primary, Bedikian, Agop, primary, Hwu, Wen-Jen, primary, Patel, Sapna, primary, Ross, Merrick I., primary, Lee, Jeffrey E., primary, Gershenwald, Jeffrey E., primary, Lucci, Anthony, primary, Royal, Richard, primary, Cormier, Janice N., primary, Davies, Michael A., primary, Mansaray, Rahmatu, primary, Fulbright, Orenthial J., primary, Toth, Christopher, primary, Ramachandran, Renjith, primary, Wardell, Seth, primary, Gonzalez, Audrey, primary, and Hwu, Patrick, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 1 from Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Author

Radvanyi, Laszlo G., primary, Bernatchez, Chantale, primary, Zhang, Minying, primary, Fox, Patricia S., primary, Miller, Priscilla, primary, Chacon, Jessica, primary, Wu, Richard, primary, Lizee, Gregory, primary, Mahoney, Sandy, primary, Alvarado, Gladys, primary, Glass, Michelle, primary, Johnson, Valen E., primary, McMannis, John D., primary, Shpall, Elizabeth, primary, Prieto, Victor, primary, Papadopoulos, Nicholas, primary, Kim, Kevin, primary, Homsi, Jade, primary, Bedikian, Agop, primary, Hwu, Wen-Jen, primary, Patel, Sapna, primary, Ross, Merrick I., primary, Lee, Jeffrey E., primary, Gershenwald, Jeffrey E., primary, Lucci, Anthony, primary, Royal, Richard, primary, Cormier, Janice N., primary, Davies, Michael A., primary, Mansaray, Rahmatu, primary, Fulbright, Orenthial J., primary, Toth, Christopher, primary, Ramachandran, Renjith, primary, Wardell, Seth, primary, Gonzalez, Audrey, primary, and Hwu, Patrick, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 5 from Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Author

Radvanyi, Laszlo G., primary, Bernatchez, Chantale, primary, Zhang, Minying, primary, Fox, Patricia S., primary, Miller, Priscilla, primary, Chacon, Jessica, primary, Wu, Richard, primary, Lizee, Gregory, primary, Mahoney, Sandy, primary, Alvarado, Gladys, primary, Glass, Michelle, primary, Johnson, Valen E., primary, McMannis, John D., primary, Shpall, Elizabeth, primary, Prieto, Victor, primary, Papadopoulos, Nicholas, primary, Kim, Kevin, primary, Homsi, Jade, primary, Bedikian, Agop, primary, Hwu, Wen-Jen, primary, Patel, Sapna, primary, Ross, Merrick I., primary, Lee, Jeffrey E., primary, Gershenwald, Jeffrey E., primary, Lucci, Anthony, primary, Royal, Richard, primary, Cormier, Janice N., primary, Davies, Michael A., primary, Mansaray, Rahmatu, primary, Fulbright, Orenthial J., primary, Toth, Christopher, primary, Ramachandran, Renjith, primary, Wardell, Seth, primary, Gonzalez, Audrey, primary, and Hwu, Patrick, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figures 1 - 7 from Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Author

Radvanyi, Laszlo G., primary, Bernatchez, Chantale, primary, Zhang, Minying, primary, Fox, Patricia S., primary, Miller, Priscilla, primary, Chacon, Jessica, primary, Wu, Richard, primary, Lizee, Gregory, primary, Mahoney, Sandy, primary, Alvarado, Gladys, primary, Glass, Michelle, primary, Johnson, Valen E., primary, McMannis, John D., primary, Shpall, Elizabeth, primary, Prieto, Victor, primary, Papadopoulos, Nicholas, primary, Kim, Kevin, primary, Homsi, Jade, primary, Bedikian, Agop, primary, Hwu, Wen-Jen, primary, Patel, Sapna, primary, Ross, Merrick I., primary, Lee, Jeffrey E., primary, Gershenwald, Jeffrey E., primary, Lucci, Anthony, primary, Royal, Richard, primary, Cormier, Janice N., primary, Davies, Michael A., primary, Mansaray, Rahmatu, primary, Fulbright, Orenthial J., primary, Toth, Christopher, primary, Ramachandran, Renjith, primary, Wardell, Seth, primary, Gonzalez, Audrey, primary, and Hwu, Patrick, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Methods from Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Author

Radvanyi, Laszlo G., primary, Bernatchez, Chantale, primary, Zhang, Minying, primary, Fox, Patricia S., primary, Miller, Priscilla, primary, Chacon, Jessica, primary, Wu, Richard, primary, Lizee, Gregory, primary, Mahoney, Sandy, primary, Alvarado, Gladys, primary, Glass, Michelle, primary, Johnson, Valen E., primary, McMannis, John D., primary, Shpall, Elizabeth, primary, Prieto, Victor, primary, Papadopoulos, Nicholas, primary, Kim, Kevin, primary, Homsi, Jade, primary, Bedikian, Agop, primary, Hwu, Wen-Jen, primary, Patel, Sapna, primary, Ross, Merrick I., primary, Lee, Jeffrey E., primary, Gershenwald, Jeffrey E., primary, Lucci, Anthony, primary, Royal, Richard, primary, Cormier, Janice N., primary, Davies, Michael A., primary, Mansaray, Rahmatu, primary, Fulbright, Orenthial J., primary, Toth, Christopher, primary, Ramachandran, Renjith, primary, Wardell, Seth, primary, Gonzalez, Audrey, primary, and Hwu, Patrick, primary

Published
2023
Full Text
View/download PDF

27. CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting

Author

Rabinowits, Guilherme, primary, Homsi, Jade, additional, Park, Soo, additional, Khushalani, Nikhil, additional, Panella, Timothy, additional, Ellison, David, additional, Gentry, Rhonda, additional, Venna, Suraj, additional, Strasswimmer, John, additional, Zuniga, Richard, additional, Chandra, Sunandana, additional, Ruiz, Emily, additional, Migden, Michael, additional, Ibrahim, Sherrif, additional, Mehta, Nikita, additional, Inocencio, Timothy, additional, He, Xuanyao, additional, Zhang, Haixin, additional, Gillis, Kathryn, additional, and Pouliot, Jean-Francois, additional

Published
2023
Full Text
View/download PDF

29. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022

Author

von Mehren, Margaret, primary, Kane, John M., additional, Riedel, Richard F., additional, Sicklick, Jason K., additional, Pollack, Seth M., additional, Agulnik, Mark, additional, Bui, Marilyn M., additional, Carr-Ascher, Janai, additional, Choy, Edwin, additional, Connelly, Mary, additional, Dry, Sarah, additional, Ganjoo, Kristen N., additional, Gonzalez, Ricardo J., additional, Holder, Ashley, additional, Homsi, Jade, additional, Keedy, Vicki, additional, Kelly, Ciara M., additional, Kim, Edward, additional, Liebner, David, additional, McCarter, Martin, additional, McGarry, Sean V., additional, Mesko, Nathan W., additional, Meyer, Christian, additional, Pappo, Alberto S., additional, Parkes, Amanda M., additional, Petersen, Ivy A., additional, Poppe, Matthew, additional, Schuetze, Scott, additional, Shabason, Jacob, additional, Spraker, Matthew B., additional, Zimel, Melissa, additional, Bergman, Mary Anne, additional, Sundar, Hema, additional, and Hang, Lisa E., additional

Published
2022
Full Text
View/download PDF

30. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Author

Gross, Neil D., primary, Miller, David M., additional, Khushalani, Nikhil I., additional, Divi, Vasu, additional, Ruiz, Emily S., additional, Lipson, Evan J., additional, Meier, Friedegund, additional, Su, Yungpo B., additional, Swiecicki, Paul L., additional, Atlas, Jennifer, additional, Geiger, Jessica L., additional, Hauschild, Axel, additional, Choe, Jennifer H., additional, Hughes, Brett G.M., additional, Schadendorf, Dirk, additional, Patel, Vishal A., additional, Homsi, Jade, additional, Taube, Janis M., additional, Lim, Annette M., additional, Ferrarotto, Renata, additional, Kaufman, Howard L., additional, Seebach, Frank, additional, Lowy, Israel, additional, Yoo, Suk-Young, additional, Mathias, Melissa, additional, Fenech, Keilah, additional, Han, Hyunsil, additional, Fury, Matthew G., additional, and Rischin, Danny, additional

Published
2022
Full Text
View/download PDF

33. Soft Tissue Sarcoma, Version 2.2022

Author

von Mehren, Margaret, Kane, John M., Agulnik, Mark, Bui, Marilyn M., Carr-Ascher, Janai, Choy, Edwin, Connelly, Mary, Dry, Sarah, Ganjoo, Kristen N., Gonzalez, Ricardo J., Holder, Ashley, Homsi, Jade, Keedy, Vicki, Kelly, Ciara M., Kim, Edward, Liebner, David, McCarter, Martin, McGarry, Sean V., Mesko, Nathan W., Meyer, Christian, Pappo, Alberto S., Parkes, Amanda M., Petersen, Ivy A., Pollack, Seth M., Poppe, Matthew, Riedel, Richard F., Schuetze, Scott, Shabason, Jacob, Sicklick, Jason K., Spraker, Matthew B., Zimel, Melissa, Hang, Lisa E., Sundar, Hema, and Bergman, Mary Anne

Subjects
Humans, Extremities, Sarcoma, Soft Tissue Neoplasms, Medical Oncology, Article
Abstract

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recommendations, and reviews the evidence to support the guidelines recommendations.

Published
2022

35. High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition

Author

Adams, Anngela C., primary, Borden, Elizabeth S., additional, Macy, Anne M., additional, Thomson, Nick, additional, Cui, Haiyan, additional, Gimbel, Mark I., additional, Wilson, Melissa A., additional, Buetow, Kenneth H., additional, Roe, Denise J., additional, DiCaudo, David J., additional, Homsi, Jade, additional, and Hastings, Karen Taraszka, additional

Published
2022
Full Text
View/download PDF

37. Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

Author

von Itzstein, Mitchell S., primary, Gonugunta, Amrit S., additional, Sheffield, Thomas, additional, Homsi, Jade, additional, Dowell, Jonathan E., additional, Koh, Andrew Y., additional, Raj, Prithvi, additional, Fattah, Farjana, additional, Wang, Yiqing, additional, Basava, Vijay S., additional, Khan, Shaheen, additional, Park, Jason Y., additional, Popat, Vinita, additional, Saltarski, Jessica M., additional, Gloria-McCutchen, Yvonne, additional, Hsiehchen, David, additional, Ostmeyer, Jared, additional, Xie, Yang, additional, Li, Quan-Zhen, additional, Wakeland, Edward K., additional, and Gerber, David E., additional

Published
2022
Full Text
View/download PDF

50. CONTRIBUTORS

Author

Aberg, Judith A., primary, Abernethy, Amy P., additional, Abrahm, Janet L., additional, Adolph, Michael, additional, Aherne, Michael, additional, Allsopp, K., additional, Altisent, Rogelio, additional, Alvarez, Carmen Fernandez, additional, Amigo, Pablo, additional, Anderson, Wendy G., additional, Ang, Sik Kim, additional, Antonelli, Tiziana, additional, Armstrong, John, additional, Armstrong, Wendy S., additional, Arnold, Robert M., additional, Arranz, Pilar, additional, Augustyns, Koen, additional, Sáenz-Diez, Isabel Barreiro-Meiro, additional, Barreto, Pilar, additional, Barton, Debra, additional, Bates, Ursula, additional, Fernandez-Creuchet Santos, Maria B., additional, Bátiz, Jacinto, additional, Benedetti, Costantino, additional, Bennani-Baiti, Nabila, additional, Bennett, Michael I., additional, Berger, Kevin, additional, Bhatnagar, Mamta, additional, Bicanovsky, Lesley, additional, Blue, Lynda, additional, Bobb, Barton, additional, Body, Jean-Jacques, additional, Borasio, Gian Domenico, additional, Borreani, Claudia, additional, Bozzetti, Federico, additional, Bozzetti, Valentina, additional, Braybrooke, Jason, additional, Breitbart, William, additional, Bresnihan, Barry, additional, Broeckaert, Bert, additional, Bruera, Eduardo, additional, Brune, Kay, additional, Buckhout, Bradley, additional, Butow, Phyllis N., additional, Byock, Ira, additional, Byrne, Anthony, additional, Byrne, Clare, additional, Cable-Williams, Beryl E., additional, Callin, Sarah E., additional, Casarett, David, additional, Casper, David, additional, Cassell, Eric J., additional, Cassileth, Barrie, additional, Castagno, Emanuele, additional, Centeno, Carlos, additional, Ceranski, Walter, additional, Ceulemans, Lucas, additional, Chadha, Meghna, additional, Chamberlain, Bruce H., additional, Chang, Eric L., additional, Chang, Victor T., additional, Chochinov, Harvey Max, additional, Chow, Edward, additional, Christ, Grace, additional, Clark, Katherine, additional, Clarke, Stephen, additional, Clayton, Josephine M., additional, Cleary, James F., additional, Clein, Lawrence J., additional, Clemens, Katri Elina, additional, Clemens, Libby, additional, Colebunders, Robert, additional, Connor, Steven R., additional, Conraads, Viviane, additional, Cooney, Colm, additional, Costantini, Massimo, additional, Couceiro, Azucena, additional, Covington, Holly, additional, Cowan, John D., additional, Coyne, Patrick, additional, Crawford, Garnet, additional, Creedon, Brian, additional, Cronin, Hilary, additional, Cullen, Garret, additional, Cummings, Jennifer E., additional, Currow, David C., additional, Daeninck, Paul J., additional, Dalinis, Pamela, additional, Das, Prajnan, additional, Davis, Mellar P., additional, Davison, Sara N., additional, Deamant, Catherine, additional, de Lima, Liliana, additional, Delany, Conor P., additional, Demeulenaere, Peter, additional, Dergham, Lena, additional, Derycke, Noël, additional, Dhupar, Rajeev, additional, Dicato, Mario, additional, Dickerson, Edwin D., additional, Dickman, Andrew, additional, Dietrich, Maria, additional, Dixon, Pamela, additional, Dodd, Philip C., additional, D'Olimpio, James T., additional, Dombernowsky, Per, additional, Dooley, Michael, additional, Dudgeon, Deborah, additional, Dunn, Geoffrey P., additional, Dunwoodie, David, additional, Eades, Jane, additional, El Osta, Badi, additional, Elbert-Avila, Katja, additional, Ellershaw, John, additional, Estfan, Bassam, additional, Exton, Louise, additional, Fairchild, Alysa, additional, Farrelly, Matthew, additional, Fassbender, Konrad, additional, Faulhaber, Jason, additional, Fearon, Kenneth C.H., additional, Fenelon, Lynda E., additional, Ferson, Peter F., additional, Feyer, Petra, additional, Filbet, Marilene, additional, Firth, Pam, additional, FitzGerald, Susan F., additional, Flood, Hugh D., additional, Floriani, Francesca Crippa, additional, Ford, Paul J., additional, Fortner, Barry, additional, Foth, Darlene, additional, Fowler, Bridget, additional, Frame, Karen, additional, Fraser, Thomas G., additional, Frost, Fred, additional, Fulham, Michael J., additional, Gagnon, Pierre R., additional, Gallagher, Lisa M., additional, Gambles, Maureen, additional, Giri, Subhasis K., additional, Glare, Paul, additional, Goh, Cynthia R., additional, Gómez-Batiste, Xavier, additional, Gramlich, Leah, additional, Grassi, Luigi, additional, Grauer, Phyllis A., additional, Green, Claire, additional, Griffiths, Gareth, additional, Griffo, Yvona, additional, Groninger, Hunter, additional, Gruenewald, David A., additional, Gubili, Jyothirmai, additional, Gutgsell, Terence L., additional, Gwyther, Elizabeth, additional, Haber, Paul S., additional, Haemers, Achiel, additional, Haley, Mindi C., additional, Hanna, Mazen A., additional, Hardy, Janet R., additional, Haselkorn, Jodie, additional, Hauser, Katherine, additional, Heaven, Cathy, additional, Herman, Michael, additional, Herrstedt, Jørn, additional, Higgins, Stephen, additional, Higginson, Irene J., additional, Hilden, Joanne M., additional, Hillenbrand, Kathryn L., additional, Hinz, Burkhard, additional, Homsi, Jade, additional, Hood, Kerry, additional, Hou, Juliet Y., additional, Hubens, Guy, additional, Hudson, Peter, additional, Hughes, John G., additional, Hunt, John, additional, Hurwitz, Craig A., additional, Ibinson, James, additional, Janjan, Nora, additional, Jaspers, Birgit, additional, Jehser, Thomas, additional, Joffe, A. Mark, additional, John, Laurence, additional, Johnstone, Jennie, additional, Jones, J. Stephen, additional, Kane, Javier R., additional, Karafa, Matthew T., additional, Keaveny, Andrew P., additional, Keefe, Dorothy M.K., additional, Kelso, Catherine McVearry, additional, Kenny, Rose Anne, additional, Kern, Martina, additional, Khoshknabi, Dilara Seyidova, additional, Kirkova, Jordanka, additional, Kirsh, Kenneth L., additional, Kissane, David W., additional, Klaschik, Eberhard, additional, Komurcu, Seref, additional, Kottke-Marchant, Kandice, additional, Kozell, Kathryn M., additional, Krishnan, Sunil, additional, Kuban, Deborah, additional, Laber, Damian A., additional, Lagman, Ruth L., additional, Lalla, Rajesh V., additional, Lane, Deforia, additional, Larkin, Philip J., additional, Lasheen, Wael, additional, Lawlor, Peter, additional, LeGrand, Susan B., additional, Lens, Vincent, additional, Leskuski, Dona, additional, Levack, Pamela, additional, Levetown, Marcia, additional, Lewandowski, Jeanne G., additional, Lewis, William R., additional, Librach, S. Lawrence, additional, Lichtenthal, Wendy G., additional, Lickiss, J. Norelle, additional, Lijoi, Stefano, additional, Lin, Edward, additional, Lipman, Arthur G., additional, Livrozet, Jean-Michel, additional, Lloyd-Williams, Mari, additional, Logan, Richard M., additional, Martín, Francisco López-Lara, additional, Loprinzi, Charles L., additional, Loughnane, John, additional, Lucey, Michael, additional, Lyckholm, Laurie, additional, Macmillan, Carol, additional, Mair, Frances, additional, Makoni, Stephen N., additional, Malik, Bushra, additional, Malone, Kevin, additional, Maltoni, Marco, additional, Mani, Aruna, additional, Marchand, Lucille R., additional, Mareiniss, Darren P., additional, Marsland, Anna L., additional, Marston, Joan, additional, Martinez, Julia Romero, additional, Martínez de Ubago, Isabel, additional, Martins, Lina M., additional, Maughan, Timothy S., additional, Mayland, Catriona, additional, McClement, Susan E., additional, McCutcheon, Ian, additional, McGee, Michael F., additional, McGill, Neil, additional, McNamara, Stephen, additional, McPherson, Mary Lynn, additional, McQuay, Henry, additional, McQuillan, Regina, additional, McQuown, Robert E., additional, Meiring, Michelle, additional, Mercadante, Sebastiano, additional, Meyer, Elaine C., additional, Miller, Randy D., additional, Millerick, Yvonne, additional, Miniero, Roberto, additional, Mohamed, Armin, additional, Mooka, Busi, additional, Morrison, Helen M., additional, Muir, J. Cameron, additional, Mulcahy, Fiona, additional, Mulcahy, Hugh E., additional, Muller, Monica, additional, Müller-Busch, H. Christof, additional, Murray, Scott A., additional, Nauck, Friedemann, additional, Neasham, Katherine, additional, Nkosi, Busisiwe, additional, Noble, Simon, additional, Noguera, Antonio, additional, Nowak, Anna K., additional, Nuñez-Olarte, Juan, additional, Obbens, Eugenie A.M.T., additional, O'Brien, Tony, additional, Olden, Megan, additional, O'Leary, Norma, additional, Oliver, David, additional, Oliviere, David, additional, Omlin, Aurelius G., additional, Osenga, Kaci, additional, O'Shea, Diarmuid, additional, Ostgathe, Christophe, additional, Ottery, Faith D., additional, Ouellette, Michel, additional, Overton, Edgar Turner, additional, Palacios, Moné, additional, Palmer, Robert, additional, Palmer, Teresa, additional, Paradis, Carmen, additional, Parala, Armida G., additional, Pascual-López, Antonio, additional, Passik, Steven D., additional, Pawlik, Timothy M., additional, Payne, Malcolm, additional, Payne, Sheila, additional, Paz, Silvia, additional, Pereira, José, additional, Perkins, George, additional, Peschardt, Karin, additional, Pessin, Hayley, additional, Peterson, Douglas E., additional, Podichetty, Vinod K., additional, Pollens, Robin, additional, Pontifex, Eliza, additional, Poole, Susan, additional, Porta-Sales, Josep, additional, Poston, Graeme, additional, Powazki, Ruth D., additional, Powderly, William, additional, Pozuelo, Leopoldo, additional, Prommer, Eric, additional, Puchalski, Christina M., additional, Radbruch, Lukas, additional, Raes, David F.J., additional, Read, Jane, additional, Reddy, Anantha, additional, Reger, Steven I., additional, Rehm, Susan J., additional, Reich, Stephen G., additional, Rocafort, Javier, additional, Rosenblatt, Adam, additional, Rushton, Cynda Hylton, additional, Russell, K. Mitchell, additional, Ryan, Karen, additional, Rybicki, Lisa A., additional, Sacerdote, Paola, additional, Sahgal, Vinod, additional, Ann Sammon, Mary, additional, Sandrock, Dirk, additional, Sands, Mark, additional, Schilling, Denise L., additional, Schulz, Valerie Nocent, additional, Schum, Lisa N., additional, Selwyn, Peter, additional, Shadd, Joshua, additional, Shapiro, Charles L., additional, Sharif, Aktham, additional, Sharp, Helen M., additional, Shepard, Kirk V., additional, Sherwood, J. Timothy, additional, Shrestha, Nabin K., additional, Skipworth, Richard J.E., additional, Smith, Howard S., additional, Solomon, Mildred Z., additional, de Prado Otero, Diego Soto, additional, Spencer, Denise Wells, additional, Spice, Ron, additional, Spiegel, David, additional, Srivastava, Manish, additional, Staffurth, John N., additional, Starling, Randall, additional, Stewart, Grant D., additional, Stjernswärd, Jan, additional, Strasser, Florian, additional, Strauss, Edna, additional, Strohscheer, Imke, additional, Summey, Brett Taylor, additional, Sutton, Graham, additional, Sykes, Nigel P., additional, Taege, Alan J., additional, Tamburini, Marcello, additional, Tarumi, Yoko, additional, Tassinari, Davide, additional, Tattersall, Martin H.N., additional, Theil, Karl S., additional, Thomas, Keri, additional, Tookman, Adrian, additional, Torrubia, María P., additional, Towers, Anna, additional, Tsoi, Daphne, additional, Tucker, Rodney O., additional, Tulsky, James A., additional, Tunick, Rachel A., additional, Turner, Claire, additional, Twaddle, Martha L., additional, Twomey, Marie, additional, Ullrich, Christina, additional, Urch, Catherine E., additional, Vachon, Mary L.S., additional, Van den Eynden, Bart, additional, Vigano, Antonio, additional, Vlieghe, Erika, additional, Volandes, Angelo E., additional, Voltz, Raymond, additional, Walker, Paul W., additional, Watanabe, Sharon, additional, Weber, Michael A., additional, Weinstein, Elizabeth, additional, Weinstein, Sharon M., additional, Weise, Kathryn L., additional, Weisenfluh, Sherri, additional, Welsh, John, additional, White, Clare, additional, Wilson, Donna M., additional, Wolfe, Joanne, additional, Yavuzsen, Tugba, additional, Yee, Albert J.M., additional, Yerian, Lisa M., additional, and Zucchetti, Elena, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results